GB201910608D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB201910608D0 GB201910608D0 GBGB1910608.7A GB201910608A GB201910608D0 GB 201910608 D0 GB201910608 D0 GB 201910608D0 GB 201910608 A GB201910608 A GB 201910608A GB 201910608 D0 GB201910608 D0 GB 201910608D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1910608.7A GB201910608D0 (en) | 2019-07-24 | 2019-07-24 | Compounds |
| PCT/GB2020/051785 WO2021014172A1 (en) | 2019-07-24 | 2020-07-24 | Pyridine derivatives as calcium-activated chloride channel modulators |
| EP20751239.3A EP4003977B1 (en) | 2019-07-24 | 2020-07-24 | Pyridine derivatives as calcium-activated chloride channel modulators |
| JP2022504580A JP7682850B2 (ja) | 2019-07-24 | 2020-07-24 | カルシウム活性化クロライドチャネルモジュレーターとしてのピリジン誘導体 |
| CN202080053457.2A CN114929683B (zh) | 2019-07-24 | 2020-07-24 | 作为钙激活氯化物通道调节剂的吡啶衍生物 |
| US17/581,520 US12545658B2 (en) | 2019-07-24 | 2022-01-21 | Pyridine derivatives as calcium-activated chloride channel modulators |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1910608.7A GB201910608D0 (en) | 2019-07-24 | 2019-07-24 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201910608D0 true GB201910608D0 (en) | 2019-09-04 |
Family
ID=67839705
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1910608.7A Ceased GB201910608D0 (en) | 2019-07-24 | 2019-07-24 | Compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12545658B2 (https=) |
| EP (1) | EP4003977B1 (https=) |
| JP (1) | JP7682850B2 (https=) |
| CN (1) | CN114929683B (https=) |
| GB (1) | GB201910608D0 (https=) |
| WO (1) | WO2021014172A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2291749A1 (fr) * | 1974-11-20 | 1976-06-18 | Delalande Sa | Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique |
| EA002113B1 (ru) * | 1996-09-04 | 2001-12-24 | Пфайзер Инк. | Производные индазола и их использование в качестве ингибиторов фосфодиэстеразы (фдэ) типа iv и продуцирования фактора некроза опухоли (фно) |
| HK1052011A1 (zh) | 2000-09-15 | 2003-08-29 | Anormed Inc. | 趋化因子受体结合杂环化合物 |
| US7642277B2 (en) * | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
| UY32138A (es) * | 2008-09-25 | 2010-04-30 | Boehringer Ingelheim Int | Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables |
| BR112014030940B1 (pt) * | 2012-06-11 | 2022-09-06 | UCB Biopharma SRL | Benzimidazóis que modulam tnf-alfa e composição farmacêutica compreendendo os mesmos |
| US9458124B2 (en) | 2013-02-06 | 2016-10-04 | Wayne State University | Substituted pyran derivatives |
| ES2735924T3 (es) * | 2015-04-17 | 2019-12-20 | Dow Agrosciences Llc | Moléculas que tienen utilidad plaguicida e intermediarios, composiciones y procesos, relacionados con ellas |
| PL3442947T3 (pl) | 2016-04-15 | 2023-10-02 | Epizyme, Inc. | Związki arylowe lub heteroarylowe podstawione aminą jako inhibitory ehmt1 i ehmt2 |
| GB201610854D0 (en) * | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
| GB201619694D0 (en) * | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
| AU2018211529A1 (en) | 2017-01-27 | 2019-08-29 | Genfit | N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxa zin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases |
| WO2018195127A1 (en) | 2017-04-17 | 2018-10-25 | The Regents Of The University Of California | Substituted 2-acylamino-cycloakylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel tmem16a |
| GB201801355D0 (en) * | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
-
2019
- 2019-07-24 GB GBGB1910608.7A patent/GB201910608D0/en not_active Ceased
-
2020
- 2020-07-24 EP EP20751239.3A patent/EP4003977B1/en active Active
- 2020-07-24 CN CN202080053457.2A patent/CN114929683B/zh active Active
- 2020-07-24 WO PCT/GB2020/051785 patent/WO2021014172A1/en not_active Ceased
- 2020-07-24 JP JP2022504580A patent/JP7682850B2/ja active Active
-
2022
- 2022-01-21 US US17/581,520 patent/US12545658B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4003977B1 (en) | 2026-04-15 |
| CN114929683A (zh) | 2022-08-19 |
| JP7682850B2 (ja) | 2025-05-26 |
| US12545658B2 (en) | 2026-02-10 |
| EP4003977A1 (en) | 2022-06-01 |
| CN114929683B (zh) | 2024-09-03 |
| JP2022541638A (ja) | 2022-09-26 |
| US20220144803A1 (en) | 2022-05-12 |
| WO2021014172A1 (en) | 2021-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289463A (en) | Agonist-gipr compounds | |
| GB201913603D0 (en) | New compounds | |
| GB201905721D0 (en) | Compounds | |
| GB201916915D0 (en) | Compounds | |
| GB201910305D0 (en) | Compounds | |
| GB201908536D0 (en) | Compounds | |
| GB201912404D0 (en) | New compounds | |
| GB201910304D0 (en) | Compounds | |
| GB201908171D0 (en) | Compounds | |
| GB201908095D0 (en) | Carboxy-MIDA-boronate compounds | |
| GB201919205D0 (en) | Compounds | |
| GB201918761D0 (en) | Compounds | |
| GB201918424D0 (en) | Compounds | |
| GB201917895D0 (en) | Compounds | |
| GB201917893D0 (en) | Compounds | |
| GB201917891D0 (en) | Compounds | |
| GB201916847D0 (en) | Compounds | |
| GB201916597D0 (en) | Compounds | |
| GB201916595D0 (en) | Compounds | |
| GB201916572D0 (en) | Compounds | |
| GB201916142D0 (en) | Compounds | |
| GB201914208D0 (en) | Compounds | |
| GB201913633D0 (en) | Compounds | |
| GB201913541D0 (en) | Compounds | |
| GB201912850D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |